Evidence map›Paper›PMID 39004185›Full record

ReviewBiomedical journal2025

Basic implications on three pathways associated with SARS-CoV-2.

Jong Hoon Lee, Consolato Sergi, Richard E Kast, Badar A Kanwar, Jean Bourbeau, Sangsuk Oh, Mun-Gi Sohn, Chul Joong Lee, Michael D Coleman

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biomedical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jong Hoon LeeScience and Research Center, Seoul National University College of Medicine, Seoul, South Korea. Electronic address: science@research.re.kr.
Consolato SergiDivision of Anatomical Pathology, Children's Hospital of Eastern Ontario (CHEO), University of Ottawa, Ottawa, ON, Canada.
Richard E KastIIAIGC Study Center, Burlington, VT, USA.
Badar A KanwarHaider Associates, Bedford, TX, USA.
Jean BourbeauRespiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montréal, QC, Canada.
Sangsuk OhDepartment of Food Engineering, Food Safety Laboratory, Memory Unit, Ewha Womans University, Seoul, South Korea.
Mun-Gi SohnDepartment of Food Science, KyungHee University College of Life Science, Seoul, South Korea.
Chul Joong LeeDepartment of Anesthesiology, Seoul National University Hospital, Seoul, South Korea.
Michael D ColemanCollege of Health and Life Sciences, Aston University, Birmingham, UK. Electronic address: m.d.coleman@aston.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) interacts between the host and virus and govern induction, resulting in multiorgan impacts. Its pathophysiology involves the followings: 1) the angiotensin-converting enzyme (ACE2) and Toll-like receptor (TLR) pathways: 2) the neuropilin (NRP) pathway: 3) the spike protein pathway. Therefore, it is necessary to block the pathological course with modulating innate lymphoid cells against diverse corona variants in the future.

Indexed as

COVID-19SARS-CoV-2Angiotensin-Converting Enzyme 2HumansImmunity, InnateSignal TransductionSpike Glycoprotein, CoronavirusToll-Like ReceptorsACE2 protein, humanAngiotensin-Converting Enzyme 2Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Toll-Like ReceptorsACE2COVID-19SARS-CoV-2Spike proteinTLR

Identifiers

PMID39004185
PMCPMC12175243

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.